CGEM   $21.08  -1.31% Market Closed After Close 21.08 0.0

Cullinan Therapeutics, Inc.

EMA (20): 2026-09-10 the price crossed down the moving average line and trying to form a short-term downside trend.

EMA (50): 2026-08-04 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-06-12 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type linear up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -1.76%
EMA (20) date of signal Sept. 10, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 17.55%
EMA (50) date of signal Aug. 4, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 50.58%
EMA (100) date of signal June 12, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.44%
RSI (14) date of signal Sept. 15, 2026, 3 a.m.
MACD Signals bearish reversal
MACD Yield -5.32%
MACD date of signal Sept. 1, 2026, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal Sept. 16, 2026, 3 a.m.
Updated Sept. 17, 2026, 11 p.m.